These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
Delaware
|
95-4106894
|
|
(State or other jurisdiction
|
(I.R.S. Employer Identification No.)
|
|
of incorporation or organization)
|
|
Large Accelerated Filer
|
Accelerated Filer
|
|
|
Non-accelerated filer
|
Smaller Reporting Company [x]
|
|
Class
|
Outstanding December 31, 2011
|
|
Common Stock, par value $0.0001 per share
|
71,845,208 shares
|
|
Index
|
Page No.
|
||
|
PART I.
|
FINANCIAL INFORMATION
|
||
|
ITEM 1.
|
Financial Statements (Unaudited)
|
||
|
Condensed Balance Sheets as of November 30, 2011 and February 28, 2011
|
4
|
||
|
Condensed Statements of Operations for the Three and Nine Months Ended November 30, 2011 and 2010
|
5
|
||
|
Condensed Statements of Cash Flows for the Nine Months Ended November 30, 2011 and 2010
|
6
|
||
|
Notes to Condensed Financial Statements
|
7
|
||
|
ITEM 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
|
|
ITEM 4T.
|
Controls and Procedures
|
19
|
|
|
PART II.
|
OTHER INFORMATION
|
||
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
20
|
|
|
ITEM 6.
|
Exhibits
|
20
|
|
|
SIGNATURES AND CERTIFICATIONS
|
21
|
||
|
November 30
|
February 28
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 146,257 | $ | 104,815 | ||||
|
Accounts receivable, net of allowance for doubtful accounts of $59,070 at November 30, 2011 and February 28, 2011, respectively
|
546,984 | 296,297 | ||||||
|
Inventory - current
|
1,000,000 | 1,000,000 | ||||||
|
Other current assets
|
650,743 | 450,843 | ||||||
|
Total current assets
|
2,343,984 | 1,851,955 | ||||||
|
Property, plant, and equipment, net
|
243,402 | 380,842 | ||||||
|
Inventory, non-current, net of allowance for obsolete inventory of $1,952,282 and $2,106,391 at November 30, 2011 and February 28, 2011, respectively
|
2,032,979 | 2,274,013 | ||||||
|
Total assets
|
$ | 4,620,365 | $ | 4,506,810 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 624,706 | $ | 1,945,372 | ||||
|
Accrued expenses
|
905,065 | 2,632,856 | ||||||
|
Customer advances
|
77,872 | 336,308 | ||||||
|
Notes payable
|
- | 82,500 | ||||||
|
Convertible notes payable
|
333,213 | 290,000 | ||||||
|
Notes payable and accrued interest- related party
|
11,367,506 | 10,148,352 | ||||||
|
Total current liabilities
|
13,308,362 | 15,435,388 | ||||||
|
Convertible notes payable
|
238,010 | 500,000 | ||||||
|
Total liabilities
|
13,546,372 | 15,935,388 | ||||||
|
Commitments and contingencies
|
- | - | ||||||
|
Stockholders' deficit :
|
||||||||
|
Common stock, $0.0001 par value; 150,000,000 and 75,000,000 shares authorized at November 30, 2011 and February 28, 2011; 71,445,208 and 60,720,956 shares issued and outstanding at November 30, 2011 and February 28, 2011
|
7,144 | 6,072 | ||||||
|
Additional paid-in capital
|
393,420,722 | 379,819,510 | ||||||
|
Accumulated deficit
|
(402,353,873 | ) | (391,254,160 | ) | ||||
|
Total stockholders' deficit
|
(8,926,007 | ) | (11,428,578 | ) | ||||
|
Total liabilities and stockholders' deficit
|
$ | 4,620,365 | $ | 4,506,810 | ||||
|
Three Months
|
Nine Months
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Net Revenues
|
$ | 527,185 | $ | 1,250,255 | $ | 2,093,955 | $ | 2,835,722 | ||||||||
|
Cost of goods sold
|
341,802 | 698,517 | 997,948 | 1,482,364 | ||||||||||||
|
Gross Profit
|
185,383 | 551,738 | 1,096,007 | 1,353,358 | ||||||||||||
|
Expenses
|
||||||||||||||||
|
Engineering, research and development expenses
|
337,631 | 472,045 | 993,411 | 1,284,700 | ||||||||||||
|
Selling, general and administrative expenses
|
2,895,689 | 2,121,240 | 10,755,327 | 7,197,289 | ||||||||||||
|
Total costs and expenses
|
3,233,320 | 2,593,285 | 11,748,738 | 8,481,989 | ||||||||||||
|
Loss from operations
|
(3,047,937 | ) | (2,041,547 | ) | (10,652,731 | ) | (7,128,631 | ) | ||||||||
|
Other income and (expense)
|
||||||||||||||||
|
Interest expense, net
|
(672,372 | ) | (211,663 | ) | (1,176,358 | ) | (670,284 | ) | ||||||||
|
Gain(Loss) on settlement of debt
|
447,585 | - | 714,340 | (57,032 | ) | |||||||||||
|
Other income (expense), net
|
85 | (826 | ) | 15,036 | (5,129 | ) | ||||||||||
|
Total other income (expense)
|
(224,702 | ) | (212,489 | ) | (446,982 | ) | (732,445 | ) | ||||||||
|
Net Loss
|
$ | (3,272,639 | ) | $ | (2,254,036 | ) | $ | (11,099,713 | ) | $ | (7,861,076 | ) | ||||
|
Total basic and diluted loss per share
|
$ | (0.05 | ) | $ | (0.04 | ) | $ | (0.17 | ) | $ | (0.14 | ) | ||||
|
Weighted average shares used to compute basic and diluted income (loss) per share*
|
70,131,472 | 56,123,980 | 66,621,897 | 54,672,840 | ||||||||||||
|
2011
|
2010
|
|||||||
|
Cash flow from operating activities:
|
||||||||
|
Net Loss
|
$ | (11,099,713 | ) | $ | (7,861,076 | ) | ||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation expense
|
137,440 | 140,083 | ||||||
|
Amortization of debt discount
|
366,830 | 72,000 | ||||||
|
(Gain) loss on settlement of debt
|
(714,340 | ) | 57,032 | |||||
|
Provision for inventory obsolescence
|
(154,109 | ) | - | |||||
|
Amortization
|
266,135 | - | ||||||
|
Stock options and warrants expense
|
3,750,513 | 128,999 | ||||||
|
Stock issued for services
|
510,000 | 803,000 | ||||||
|
Beneficial conversion feature on convertible debt
|
70,641 | - | ||||||
|
(Increase) decrease in:
|
||||||||
|
Accounts receivable
|
(250,687 | ) | (392,415 | ) | ||||
|
Inventory
|
395,143 | 143,164 | ||||||
|
Other current assets and deposit
|
(33,326 | ) | 36,268 | |||||
|
Cash overdraft
|
- | 67,393 | ||||||
|
Accounts payable, customer deposit and accrued expenses
|
763,895 | 2,210,963 | ||||||
|
Net cash used in operations
|
(5,991,578 | ) | (4,594,589 | ) | ||||
|
Investing activities:
|
||||||||
|
Acquisition of plant and equipment
|
- | (9,599 | ) | |||||
|
Financing activities:
|
||||||||
|
Issuance of common stock
|
1,453,520 | 1,453,894 | ||||||
|
Proceeds from stock to be issued
|
- | 50,000 | ||||||
|
Proceeds from notes payable, net
|
3,604,500 | 145,000 | ||||||
|
Proceeds from notes payable, related party, net
|
975,000 | 2,910,000 | ||||||
|
Net cash provided by financing activities
|
6,033,020 | 4,558,894 | ||||||
|
Net increase (decrease) in cash & cash equivalents
|
41,442 | (45,294 | ) | |||||
|
Cash and cash equivalents at beginning of period
|
104,815 | 45,294 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 146,257 | $ | - | ||||
|
Supplemental disclosures of cash flow information
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$ | 60,136 | $ | 17,562 | ||||
|
November 30, 2011
|
February 28, 2011
|
|||||||
|
Raw materials
|
$ | 2,373,318 | $ | 2,394,502 | ||||
|
Finished goods
|
2,611,942 | 2,985,902 | ||||||
| 4,985,260 | 5,380,404 | |||||||
|
Reserve for potential product obsolescence
|
(1,822,517 | ) | (1,991,241 | ) | ||||
| 3,162,743 | 3,389,163 | |||||||
|
Non-current portion
|
(2,032,979 | ) | (2,274,013 | ) | ||||
|
Discount on long term inventory
|
(129,764 | ) | (115,150 | ) | ||||
|
Current portion
|
$ | 1,000,000 | $ | 1,000,000 | ||||
|
November 30, 2011
|
February 28, 2011
|
|||||||
|
Machinery and equipment
|
$ | 964,111 | $ | 964,111 | ||||
|
Furniture and fixtures
|
163,302 | 163,302 | ||||||
|
Leasehold improvements
|
485,080 | 485,080 | ||||||
| 1,612,493 | 1,612,493 | |||||||
|
Less accumulated depreciation
|
(1,369,091 | ) | (1,231,651 | ) | ||||
|
Property, plant and equipment, net
|
$ | 243,402 | $ | 380,842 | ||||
|
November 30, 2011
|
February 28, 2011
|
|||||||
|
Demand note payable, at 10%
|
$ | - | $ | 82,500 | ||||
|
Convertible note payable, at 7%, convertible into common stock at $3 per share plus accrued interest, due in May 2013. This note was converted into 666,667 shares at face value plus $17,522 of accrued interest on November 30, 2011.
|
- | 500,000 | ||||||
|
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due in September2011. This note was converted into 325,612 shares at face value plus $40,953 of accrued interest as of November 30, 2011.
|
- | 200,000 | ||||||
|
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due in September 2011.
|
- | 90,000 | ||||||
|
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature at September 30, 2011
|
571,223 | - | ||||||
| 571,223 | 872,500 | |||||||
|
Less: Current portion
|
$ | 333,213 | $ | 372,500 | ||||
|
Long-term portion
|
$ | 238,010 | $ | 500,000 | ||||
|
November 30, 2011
|
February 28, 2011
|
|||||||
|
Demand note payable, at 10%, due on demand to a member of our board of directors.
|
$ | 8,500,000 | $ | 8,500,000 | ||||
|
Demand note payable, at 10%, due on demand to a member of our board of directors.
|
975,000 | - | ||||||
|
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due on demand to our CEO. This note was converted into 540,661 shares at face value plus $45,496 of accrued interest as of November 30, 2011.
|
- | 360,000 | ||||||
|
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due on demand to our former president. This note was converted into 105,413 shares at face value plus $11,331of accrued interest as of November 30, 2011.
|
- | 50,000 | ||||||
|
Accrued interest
|
1,892,506 | 1,238,352 | ||||||
| $ | 11,367,506 | $ | 10,148,352 | |||||
|
November 30, 2011
|
February 28, 2011
|
|||||||
|
Accrued payroll and related expenses
|
$ | 861,740 | $ | 2,520,107 | ||||
|
Accrued interest
|
- | 112,749 | ||||||
|
Other
|
43,325 | - | ||||||
|
Total
|
$ | 905,065 | $ | 2,632,856 | ||||
|
2006 Plan
|
|||||||
|
Weighted-Average Exercise Price
|
Aggregate Intrinsic Value
|
Number of Options
|
|||||
|
Outstanding, February 28, 2011
|
$0.75
|
$0.00
|
5,304,500
|
||||
|
Granted
|
$0.75-$1.00
|
$0.00
|
1,319,000
|
||||
|
Cancelled
|
$0.75
|
$0.00
|
(207,278)
|
||||
|
Outstanding, November 30, 2011
|
$0.75-$1.00
|
$0.00
|
6,416,222
|
||||
|
Options Outstanding
|
Exercisable Options
|
||||||||||||||||||
|
Range of Exercise
Price
|
Number
|
Weighted Average Remaining Life
|
Weighted Average Exercise Price
|
Weighted Average Remaining Life
|
Number
|
Weighted Average Exercise Price
|
|||||||||||||
|
$0.75-$1.00
|
6,416,222
|
3.1 years
|
$
|
0.80
|
2.8 years
|
5,000,305
|
$
|
0.76
|
|||||||||||
|
Number of Shares
|
Exercise Prices
|
||
|
Outstanding, February 28, 2011
|
8,688,576
|
$0.75-$4.00
|
|
|
Granted
|
23,102,787
|
$1.00-$1.50
|
|
|
Expired
|
(275,808)
|
$1.00-$4.00
|
|
|
Outstanding, November 30, 2011
|
31,515,555
|
$0.75-$4.00
|
|
Stock Warrants Granted
|
Risk free rate of return
|
Volatility
|
Dividend Yield
|
Expected Life
|
| 9,000,000 | 0.98% | 78.99% | 0% | 5 years |
| 400,00 | 0.625% | 78.83% | 0% | 5 years |
|
Range of Exercise Prices
|
Stock Warrants Outstanding
|
Stock Warrants Exercisable
|
Weighted-Average Remaining Contractual Life
|
Weighted-Average Exercise Price of Warrants Outstanding
|
Weighted-Average Exercise Price of Warrants Exercisable
|
Intrinsic Value
|
||||||
|
$1.00
|
6,225,000
|
5,825,000
|
58 months
|
$1.00
|
$1.00
|
$0.00
|
||||||
|
$1.00
|
16,722,787
|
8,872,787
|
56 months
|
$1.00
|
$1.00
|
$0.00
|
||||||
|
$1.50
|
155,000
|
155,000
|
52 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$0.75-1.50
|
2,693,286
|
2,693,286
|
38 months
|
$0.90
|
$0.90
|
$0.00
|
||||||
|
$0.75-1.25
|
1,314,710
|
1,314,710
|
32 months
|
$1.25
|
$1.25
|
$0.00
|
||||||
|
$1.50
|
1,900,000
|
1,900,000
|
31 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
|
$1.00-$4.00
|
1,934,991
|
1,934,991
|
5 months
|
$3.90
|
$3.90
|
$0.00
|
||||||
|
$4.00
|
569,781
|
569,781
|
2 months
|
$4.00
|
$4.00
|
$0.00
|
||||||
|
31,515,555
|
23,265,555
|
|
November 30, 2011
|
November 30, 2010
|
|||||||
|
United States
|
$ | 1,511,131 | $ | 2,083,848 | ||||
|
Canada
|
467,184 | 430,786 | ||||||
|
Europe
|
59,247 | 6,580 | ||||||
|
Asia
|
34,725 | 307,008 | ||||||
|
Other
|
21,668 | 7,500 | ||||||
|
Total
|
$ | 2,093,955 | $ | 2,835,722 | ||||
|
·
|
Our ability to generate positive cash flow from operations;
|
|
·
|
Our ability to obtain additional financing to fund our operations;
|
|
·
|
Our business development and operating development; and
|
|
·
|
Our expectations of growth in demand for our products.
|
|
10.63
|
Demand Promissory Note dated September 16, 2011 by and between the Company and Warren Breslow in the original principal amount of $250,000.
|
|
10.64
|
Demand Promissory Note dated September 23, 2011 by and between the Company and Warren Breslow in the original principal amount of $250,000.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|